当前位置:首页 >财报库 > 报告详情

百时美施贵宝Bristol Myers Squibb(BMY)2025年第二季度财报(10-Q)「NYSE」(英文版)(59页).pdf

上传人: 1****1 编号:923190 2025-09-24 59页 558.98KB

下载:

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-Q_ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30,2025OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For

2、the transition period from _ to _Commission File Number 001-01136_BRISTOL-MYERS SQUIBB COMPANY(Exact name of registrant as specified in its charter)_Delaware 22-0790350(State or other jurisdiction ofincorporation or organization)(I.R.S EmployerIdentification No.)Route 206&Province Line Road,Princeto

3、n,New Jersey 08543(Address of principal executive offices)(Zip Code)(609)252-4621(Registrants telephone number,including area code)_(Former name,former address and former fiscal year,if changed since last report)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Sym

4、bol(s)Name of each exchange on which registeredCommon Stock,$0.10 Par ValueBMYNew York Stock Exchange1.750%Notes due 2035BMY35New York Stock ExchangeCelgene Contingent Value RightsCELG RTNew York Stock ExchangeIndicate by check mark whether the registrant(1)has filed all reports required to be filed

5、 by Section 13 or 15(d)of the Securities Exchange Act of 1934 duringthe preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to the filing requirements for thepast 90 days.Yes No Indicate by check mark whether the registrant has

6、 submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit suchfiles).Yes No Indicate by check mark whether the regis

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,以下是Bristol-Myers Squibb Company(BMS)2025年第二季度报告的关键点: - **季度收入**:净产品销售额为11.909亿美元,总营收为12.269亿美元。 - **盈利情况**:净收入为1.310亿美元,每股收益为0.64美元。 - **研发支出**:研发费用为2.580亿美元。 - **联盟收入**:联盟收入为119亿美元。 - **收购与剥离**:完成了对2seventy bio和Karuna的收购,并进行了糖尿病业务和其他产品的剥离。 - **财务状况**:截至2025年7月24日,流通股为20.354亿股。 - **财务预测**:预计2023年重组计划的总费用约为25亿美元,截至2025年6月30日已发生14亿美元。 - **税务**:有效税率为25.9%,2025年上半年收入税支付为18亿美元。
**业绩如何?** **研发进展如何?** **合作动态揭秘**
客服
商务合作
小程序
服务号
折叠